Compare Abbott India with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs DR. DATSONS LABS - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA DR. DATSONS LABS ABBOTT INDIA/
DR. DATSONS LABS
 
P/E (TTM) x 59.3 -10.9 - View Chart
P/BV x 17.6 0.2 10,815.4% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 ABBOTT INDIA   DR. DATSONS LABS
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
DR. DATSONS LABS
Mar-14
ABBOTT INDIA/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs8,834126 7,033.5%   
Low Rs5,45831 17,661.8%   
Sales per share (Unadj.) Rs1,731.1133.0 1,301.7%  
Earnings per share (Unadj.) Rs211.90.2 139,778.9%  
Cash flow per share (Unadj.) Rs219.96.6 3,327.7%  
Dividends per share (Unadj.) Rs65.000-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs945.2128.8 733.9%  
Shares outstanding (eoy) m21.2531.66 67.1%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x4.10.6 701.6%   
Avg P/E ratio x33.7516.1 6.5%  
P/CF ratio (eoy) x32.511.8 274.4%  
Price / Book Value ratio x7.60.6 1,244.3%  
Dividend payout %30.70-   
Avg Mkt Cap Rs m151,8482,477 6,129.4%   
No. of employees `0003.5NA-   
Total wages/salary Rs m4,35656 7,778.2%   
Avg. sales/employee Rs Th10,555.5NM-  
Avg. wages/employee Rs Th1,249.9NM-  
Avg. net profit/employee Rs Th1,292.2NM-  
INCOME DATA
Net Sales Rs m36,7864,211 873.7%  
Other income Rs m1,13379 1,439.5%   
Total revenues Rs m37,9194,289 884.1%   
Gross profit Rs m6,047569 1,063.5%  
Depreciation Rs m169204 82.8%   
Interest Rs m23430 5.2%   
Profit before tax Rs m6,98913 55,027.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4856 40,741.0%   
Profit after tax Rs m4,5035 93,818.8%  
Gross profit margin %16.413.5 121.7%  
Effective tax rate %35.648.0 74.0%   
Net profit margin %12.20.1 10,738.4%  
BALANCE SHEET DATA
Current assets Rs m27,6106,852 403.0%   
Current liabilities Rs m8,5696,711 127.7%   
Net working cap to sales %51.83.3 1,545.7%  
Current ratio x3.21.0 315.6%  
Inventory Days Days60161 37.4%  
Debtors Days Days27318 8.6%  
Net fixed assets Rs m1,0573,673 28.8%   
Share capital Rs m213317 67.1%   
"Free" reserves Rs m19,8733,761 528.4%   
Net worth Rs m20,0864,078 492.6%   
Long term debt Rs m01,671 0.0%   
Total assets Rs m29,40912,633 232.8%  
Interest coverage x311.61.0 30,266.5%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.30.3 375.3%   
Return on assets %15.43.4 446.9%  
Return on equity %22.40.1 19,045.6%  
Return on capital %34.97.7 454.9%  
Exports to sales %022.9 0.0%   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNA964 0.0%   
Imports (cif) Rs mNA602 0.0%   
Fx inflow Rs m369964 38.3%   
Fx outflow Rs m4,918607 810.1%   
Net fx Rs m-4,549357 -1,274.7%   
CASH FLOW
From Operations Rs m4,9911,345 371.2%  
From Investments Rs m-2,570-2,256 113.9%  
From Financial Activity Rs m-1,428-1,200 119.0%  
Net Cashflow Rs m993-2,111 -47.1%  

Share Holding

Indian Promoters % 0.0 4.5 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 0.0 -  
FIIs % 0.1 1.4 7.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 94.1 18.2%  
Shareholders   18,270 20,807 87.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   DIVIS LABORATORIES  WOCKHARDT  VENUS REMEDIES  PANACEA BIOTECH  GLENMARK PHARMA  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 995 Points Higher; Banking and IT Stocks Witness Huge Buying(Closing)

Indian share markets continued their momentum during closing hours today and ended on a strong note.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Protect Your Wealth from Fund Managers(Fast Profits Daily)

May 14, 2020

Do you know how much you are paying in fees to your mutual fund? In this video I'll share with you my views.

How Commodity Prices Tell You When Stocks Will Go Up(Fast Profits Daily)

May 20, 2020

Commodity prices often provide clues to big moves in stock markets. In today's video, I'll explain this link.

This 'Essential Product' Smallcap is a Must Have for a 'Covid-19' Immune Portfolio(Profit Hunter)

May 19, 2020

This smallcap company needs no stimulus measures to do well in the long term.

Which Stocks Should You Buy, Sell, and Hold in the Market Today?(Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

Why Buffet - and you - should study Quantum Liquid Fund(The Honest Truth)

May 14, 2020

Ajit Dayal on how Quantum Liquid Fund and Warren Buffett have similar investing styles.

More

Get Rich as the
Market Rebounds from Covid-19

Coronavirus Rebound
Get this special guide, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


May 27, 2020 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - ALEMBIC PHARMA COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS